FDA Approved: METHSUXIMIDE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' original application for methsuximide, a generic anticonvulsant used to treat absence seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures
• Epilepsy

Drugs mentioned

• METHSUXIMIDE (METHSUXIMIDE)

Snippet

ORIG AP for METHSUXIMIDE (METHSUXIMIDE)